作者的详细信息

Novik, A. V

栏目 标题 文件
编号 8 (2016) Articles COMBINATION OF VEMURAFENIB+KOBIMETINIB FUNDAMENTALLY CHANGES PROGNOSIS FOR METASTATIC MELANOMA
编号 17 (2016) Articles ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
编号 7 (2018) Articles PRINCIPLES OF MODERN IMMUNOTHERAPY
卷 26, 编号 7 (2019) Articles Prognostic markers for testicular germ cell tumors. Research perspectives
卷 26, 编号 7 (2019) Articles Modern immunotherapy for kidney cancer
卷 26, 编号 7 (2019) Articles PEComas: what are the treatment options? Literature review and personal experience
卷 27, 编号 7 (2020) Articles Comparison of systems for evaluating the effectiveness of modern immunotherapy
卷 27, 编号 11 (2020) Articles Ten-year experience of pharmacotherapy for soft tissue sarcomas
卷 27, 编号 11 (2020) Articles The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
卷 28, 编号 7 (2021) Articles Experience of using prolgolimab in real clinical practice
卷 28, 编号 7 (2021) Articles Immunological aspects of metronomic chemotherapy regimens
卷 28, 编号 7 (2021) Articles Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma
卷 28, 编号 11 (2021) Articles Neoadjuvant immunotherapy for non-small cell lung cancer
卷 29, 编号 7 (2022) Articles The use of pazopanib in the treatment of disseminated soft tissue sarcoma: personal experience
卷 29, 编号 11/12 (2022) Articles Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma
##common.cookie##